Health
Milford mum first to receive groundbreaking new MS treatment
A MILFORD HAVEN mum has become the first NHS patient in the UK to be treated with a new drug to prevent relapses of multiple sclerosis (MS).
The newly approved medication, ublituximab, is given through an intravenous (IV) infusion and used to help treat relapses of MS.
Compared to other treatments, the drug can be given much faster through an IV infusion, allowing more patients to be treated sooner.
MS, a lifelong condition, happens when a person’s immune system attacks their brain and spinal cord.
The immune system creates cells that attack and kill viruses in the body but for those with MS, the cells attack the nerves instead.
This week, Monday 28th April to Sunday 4th May marks MS Awareness Week.
Fiona Creelie, from Milford Haven, was the first patient to be treated with the new drug at the Jill Rowe Neurology Ambulatory Unit at Morriston Hospital in Swansea.
“I started experiencing pins and needles and sharp shooting pains in my face in September,” the 35-year-old said.
“They initially thought it was trigeminal neuralgia, which is sudden, severe facial pain.
“In November, I started to get the same sensations down my right arm, so I went to A&E and had an MRI scan and lots of other tests and then was referred to Morriston Hospital.”
The mum-of-one only officially received her diagnosis of MS and just two weeks later received her first IV treatment of the new drug.
Fiona added: “I was offered a selection of three drugs, but I picked this one because it fitted in with our family life.
“This treatment will be once every six months for just an hour each time, so it was the best fit for me.
“It’s a bit crazy to have been the first person to receive the treatment but it’s also really exciting.”
With the new treatment able to be given much quicker, it will help to reduce the time patients wait for treatment.
Dr Owen Pearson, consultant neurologist at Morriston Hospital, said: “The drug itself is a new version of an already approved drug, but the advantage is that it’s given faster, through an IV infusion.
“It allows us to treat more patients per day and that allows us to shorten the waiting time for treatment.
“It is a highly effective treatment which helps to stop focal inflammation, which is new lesions appearing on an MRI, or having new relapses of MS.
“The unit was starting to operate above capacity so the introduction of this drug will help with that.
“Clinical trials for the drug were done in other centres in the UK, including Cardiff, and it has recently been approved for use on the NHS.
“Being able to offer it so quickly to our patients in Swansea Bay involves a lot of working together with the pharmacy department.
“We have a dedicated clinical pharmacist within our team which allows us to deliver new treatments like this to our patients.”
Charles-Henry Her, the team’s clinical pharmacist, added: “The consultants are really proactive in finding out about these new drugs and then they provide me with all of the information I need.
“I learn about the new drugs and how they work and make sure our systems are ready for us to introduce them.”
Around 2,200 MS patients are supported in Swansea Bay, with the service seeing patients from Machynlleth, in Powys, right across to Cowbridge, in the Vale of Glamorgan.
Dr Gillian Ingram, consultant neurologist, said: “The fact that the treatment is much shorter will allow more MS patients to come through.
“It is also beneficial for patients to have a choice of treatment, so they can choose the option that’s right for them.
“There are always new developments in treatments for MS and it is really nice to keep Wales at the forefront of that.”
Alexandra Strong, Jill Rowe Neurology Ambulatory Unit manager, said: “It is exciting for both patients and our unit to have another treatment available for MS, and it was exciting for us to be the first to give the treatment in the NHS.
“It is another option for patients to help improve their treatment and health.
“It will allow more flexibility for patients as it will make it much easier to fit in with their lifestyle, while it will also allow us to be more flexible with the treatment we can offer too.”
Health
Major investment confirmed for GP services in Wales
Government unveils £41m boost, but practices warn pressures remain acute
MORE than £41m in extra funding will go into general practice in Wales this year following a new agreement between the Welsh Government, NHS Wales and GP leaders. Ministers say the deal provides stability at a time of rising demand — but the settlement comes against a backdrop of sustained pressures, recruitment challenges and concerns over patient access.
The package includes a 4% uplift to the General Medical Services (GMS) contract for 2025-26, in line with independent DDRB pay recommendations, and a guaranteed 5.8% recurrent uplift from 2026-27. The Welsh Government says the multi-year commitment will allow practices to plan ahead, modernise systems and strengthen community-based services.
Health Secretary Jeremy Miles said the investment showed an “unwavering commitment” to general practice, adding: “The 4% pay uplift ensures fair recognition for GPs and practice staff who work tirelessly to deliver care for communities across our country. Multi-year funding gives practices the confidence to invest in the transformation primary care needs.”
However, the announcement comes at a time when many Welsh practices continue to report severe workforce pressures, rising demand, and longstanding challenges in recruiting new partners. GP numbers have fallen over the past decade, with some practices handing back contracts or operating list closures because of unsustainable workloads. Patient satisfaction with access has also declined, according to the latest Welsh GP Patient Survey.
What the deal includes
The settlement for 2025-26 comprises £37.9m of new investment and £4m in re-invested capacity funding, with the key elements including:
- A 1.77% uplift in expenses, intended to help practices manage inflationary pressures in energy, staffing and running costs.
- A recurrent £20m stabilisation fund to support practices facing immediate operational pressures and to prepare for wider reform under the incoming Sustainable Farming Scheme model for health.
- An increased partnership premium, aimed at retaining experienced GPs and encouraging new partners into a model that some say has become less attractive due to financial and regulatory risk.
- A full review of the GMS allocation formula — the first in more than 20 years — which determines how funding is distributed between practices. Some rural and deprived communities have long argued the current system does not reflect the complexity of local health needs.
Wider context
General practice remains the foundation of the NHS, accounting for around 90% of patient contacts, yet it receives a proportionally small share of the overall health budget compared with hospital services. Both the Welsh NHS Confederation and GPC Wales have repeatedly warned that without sustained investment, primary care risks being unable to meet increasing demand from ageing populations and rising chronic illness.
The Welsh Government’s own “community-by-design” programme relies on shifting more care closer to home, reducing pressure on emergency departments and supporting earlier intervention. For that to be achieved, GP leaders say investment needs to be matched with workforce expansion, improved digital systems, and clear strategies to retain experienced clinicians.
Working groups will now be set up to examine access standards, diabetes prevention and new service models.
Mr Miles said he was pleased that GPs would be “actively contributing to creating innovative care models that enhance access, improve outcomes and deliver care locally.”
GP representatives broadly welcomed the deal but have stressed that it is only one step in addressing the scale of challenge across primary care.
Health
Welsh NHS leaders hail GP contract deal as “vital step” in strengthening primary care
Agreement secures investment, digital upgrades and better patient pathways
WELSH NHS leaders have welcomed the successful conclusion of the new General Medical Services (GMS) contract for 2025-26 — and key elements of 2026-27 — describing it as a “positive example of social partnership” at a pivotal moment for general practice.
The deal, negotiated between Welsh Government, the Welsh NHS Confederation and GP representatives, sets out new investment and commitments for frontline primary care, including accelerated digital transformation through the NHS Wales App and strengthened support for population-level health management.
Darren Hughes, director of the Welsh NHS Confederation, said the agreement comes at a crucial time for GP services across Wales.
He said: “NHS leaders welcome this agreement as a positive example of social partnership in action. We also welcome the commitment to accelerating digital transformation for patients through the NHS Wales App and the measures agreed in the contract to enable enhanced population health management, such as diabetes management.”
Mr Hughes added that GPs and their multidisciplinary teams remain “the front door to the NHS,” and stressed that investment in general practice is essential if Wales is to treat more people closer to home.
“Evidence shows investing in primary and community care reduces demand on hospitals and emergency care and delivers returns of £14 for every £1 invested. To enable this shift ‘upstream’ from hospital-centred care to integrated services in the community, we must develop care pathways and joint performance measures that address the full needs of individuals,” he said.
Background: Why the GP contract matters
General practice forms the foundation of the Welsh NHS, handling millions of patient contacts every year. According to the latest official figures for 2023-24:
- Over 29 million calls were received by GP practices
- 18 million appointments took place
- 11 million of these were face-to-face
- More than 200,000 home visits were carried out
- 78 million prescriptions were dispensed
- Over 14,000 medication reviews took place
Demand has continued to rise while GP numbers have come under sustained pressure, particularly in rural areas such as Pembrokeshire, Ceredigion and Powys, where recruitment remains a long-running challenge. Practices in West Wales have repeatedly reported difficulties filling vacancies and increasing reliance on multidisciplinary teams, including nurse practitioners, pharmacists and physiotherapists.
The new GMS contract is therefore seen as a key mechanism for stabilising the sector, supporting digital access, improving chronic disease management, and helping to deliver the Welsh Government’s community-by-design programme, which aims to shift care away from hospitals and into community settings.
A recent survey by the Welsh NHS Confederation found that 74 per cent of NHS leaders support moving resources from acute hospital services into primary care, community-based services, mental health and social care, reflecting growing consensus around early intervention and prevention.
What comes next
The Welsh Government is expected to outline further detail in the coming months on how investment will be delivered at practice level, including support for digital tools, workforce development and shared performance measures with health boards.
With winter pressures mounting and hospitals facing record demand, NHS leaders say the success of the new GP contract will be central to improving access, reducing waiting times and ensuring patients in communities such as Pembrokeshire, Carmarthenshire and Ceredigion can receive timely, local care before conditions escalate.
The Welsh NHS Confederation represents all seven local health boards, the three NHS trusts, Health Education and Improvement Wales, and Digital Health and Care Wales.
Charity
Motorcycle fundraisers transform children’s play area at Glangwili Hospital
Long-running 3 Amigos and Dollies group marks 25 years of support
THANKS to outstanding fundraising by the Pembrokeshire-based 3 Amigos and Dollies Motorcycle Group, Hywel Dda Health Charities has funded a major improvement of the outdoor play area at Cilgerran children’s ward in Glangwili Hospital — a project costing more than £15,000.
The 3 Amigos and Dollies have supported Hywel Dda University Health Board’s children’s services for twenty-five years, with their Easter and Christmas toy runs becoming landmark dates in the local calendar, drawing hundreds of bikers and supporters from across west Wales.
The latest funding has delivered a full transformation of the ward’s outdoor space, including a re-sprayed graffiti wall, new toys and play equipment, a summer house, improved storage, and a moveable ramp to make the area more accessible for young patients. Members of the group even volunteered to help paint and refresh the space themselves.
Paula Goode, Service Director for Planned and Specialist Care, said: **“We are so grateful to the 3 Amigos and Dollies Motorcycle Group for their amazing support. Not only have they raised an incredible amount for the ward, but they have given their time to help make the outdoor space as special as possible.
“Outdoor play greatly reduces stress and anxiety for children, and it provides a vital opportunity to meet other young people going through similar experiences. It benefits both their physical and mental wellbeing, so we couldn’t be happier with the transformation.”
Tobi Evans, a volunteer with the fundraising group, said: “Because of the generosity of everyone who donates, we are able to give thousands each year. We are always humbled by how much people give, and it’s thanks to them that we’ve reached our 25th year.”
Katie Hancock, Fundraising Officer for Hywel Dda Health Charities, added: “We can’t thank the 3 Amigos and Dollies enough for their support for Cilgerran ward. You have put a smile on so many faces. Diolch yn fawr!”
Hywel Dda Health Charities funds items, equipment and activities that go beyond core NHS funding, making a meaningful difference to children and families across mid and west Wales.
-
Crime6 days agoPhillips found guilty of raping baby in “worst case” judge has ever dealt with
-
Crime5 days agoKilgetty scaffolder sentenced after driving with cocaine and in system
-
Crime5 days agoHousing site director sentenced after failing to provide breath sample following crash
-
News20 hours agoDyfed-Powys Police launch major investigation after triple fatal crash
-
Crime5 days agoMotorist banned for three years after driving with cannabis in system
-
Crime2 days agoMan spared jail after baseball bat incident in Milford Haven
-
Education4 days agoTeaching assistant struck off after asking pupil for photos of her body
-
News7 days agoJury retires tomorrow in harrowing Baby C rape trial








